Pyxis Oncology is trading 5.9% up at $3.24, supported mainly by a stronger biotechnology sector, with XBI up 2.06% during the regular session.

  • No new company-specific announcement dated August 26, 2026 was identified.
  • The latest official release, dated August 13, covered second-quarter results, MICVO milestones, and financing.
  • The broader market remains cautious, making sector momentum more relevant than macro conditions.